» Articles » PMID: 16430396

Breast Cancer in Limited-resource Countries: Diagnosis and Pathology

Overview
Journal Breast J
Publisher Wiley
Date 2006 Jan 25
PMID 16430396
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

In 2002 the Breast Health Global Initiative (BHGI) convened a panel of breast cancer experts and patient advocates to develop consensus recommendations for diagnosing breast cancer in countries with limited resources. The panel agreed on the need for a pathologic diagnosis, based on microscopic evaluation of tissue specimens, before initiating breast cancer treatment. The panel discussed options for pathologic diagnosis (fine-needle aspiration biopsy, core needle biopsy, and surgical biopsy) and concluded that the choice among these methods should be based on available tools and expertise. Correlation of pathology, clinical, and imaging findings was emphasized. A 2005 BHGI panel reaffirmed these recommendations and additionally stratified diagnostic and pathology methods into four levels--basic, limited, enhanced, and maximal--from lowest to highest resources. The minimal requirements (basic level) include a history, clinical breast examination, tissue diagnosis, and medical record keeping. Fine-needle aspiration biopsy was recognized as the least expensive reliable method of tissue sampling, and the need for comparing its clinical usefulness with that of core needle biopsy in the limited-resource setting was emphasized. Increasing resources (limited level) may enable diagnostic breast imaging (ultrasound +/- mammography), use of tests to evaluate for metastases, limited image-guided sampling, and hormone receptor testing. With more resources (enhanced level), diagnostic mammography, bone scanning, and an onsite cytologist may be possible. Mass screening mammography is introduced at the maximal-resource level. At all levels, increasing breast cancer awareness, diagnosing breast cancer at an early stage, training individuals to perform and interpret breast biopsies, and collecting statistics about breast cancer, resources, and competing priorities may improve breast cancer outcomes in countries with limited resources. Expertise in pathology was reaffirmed to be a key requirement for ensuring reliable diagnostic findings. Several approaches were again proposed for improving breast pathology, including training pathologists, establishing pathology services in centralized facilities, and organizing international pathology services.

Citing Articles

Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure.

Dezhakam E, Vayghan R, Dehghani S, Kafili-Hajlari T, Naseri A, Dadashpour M Sci Rep. 2024; 14(1):29850.

PMID: 39617770 PMC: 11609286. DOI: 10.1038/s41598-024-78836-y.


Comparison of clinical characteristics and outcomes in primary neuroendocrine breast carcinoma versus invasive ductal carcinoma.

Peng L, Ma M, Zhao D, Zhao J, Sun Q, Mao F Front Oncol. 2024; 14:1291034.

PMID: 38800403 PMC: 11116559. DOI: 10.3389/fonc.2024.1291034.


[Adequacy of histopathology request forms and pathological reports of breast cancer surgical specimens in Benin].

Gnangnon F, Seidou F, Laleye C, Odidi F, Flenon Nakou A, Tonato Bagnan J Med Trop Sante Int. 2024; 3(4).

PMID: 38390014 PMC: 10879892. DOI: 10.48327/mtsi.v3i4.2023.348.


NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings.

Serventi F, Musyoka A, Saunders J, Mremi A, Mmbaga B, Patrick E JCO Glob Oncol. 2022; 8:e2200192.

PMID: 36542825 PMC: 10166386. DOI: 10.1200/GO.22.00192.


Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities in subjects who show possible symptoms of suspected breast cancer.

Singh A, Bhat V, Sudhakar S, Namachivayam A, Gangadharan C, Pulchan C BMJ Open. 2021; 11(10):e052098.

PMID: 34667011 PMC: 8527152. DOI: 10.1136/bmjopen-2021-052098.